377 related articles for article (PubMed ID: 24417680)
21. Effects of formulation and process variables on the aggregation of freeze-dried interleukin-6 (IL-6) after lyophilization and on storage.
Lueckel B; Helk B; Bodmer D; Leuenberger H
Pharm Dev Technol; 1998 Aug; 3(3):337-46. PubMed ID: 9742554
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the physical stability of freeze-dried sucrose-containing formulations by differential scanning calorimetry.
te Booy MP; de Ruiter RA; de Meere AL
Pharm Res; 1992 Jan; 9(1):109-14. PubMed ID: 1589394
[TBL] [Abstract][Full Text] [Related]
23. The impact of drying method and formulation on the physical properties and stability of methionyl human growth hormone in the amorphous solid state.
Abdul-Fattah AM; Lechuga-Ballesteros D; Kalonia DS; Pikal MJ
J Pharm Sci; 2008 Jan; 97(1):163-84. PubMed ID: 17722086
[TBL] [Abstract][Full Text] [Related]
24. Existence of a mannitol hydrate during freeze-drying and practical implications.
Yu L; Milton N; Groleau EG; Mishra DS; Vansickle RE
J Pharm Sci; 1999 Feb; 88(2):196-8. PubMed ID: 9950638
[TBL] [Abstract][Full Text] [Related]
25. Influence of ethanol on physical state of freeze-dried mannitol.
Takada A; Nail SL; Yonese M
Pharm Res; 2009 May; 26(5):1112-20. PubMed ID: 19184373
[TBL] [Abstract][Full Text] [Related]
26. Stabilization of rasburicase and physico-chemical characterization of the resulting injectable formulation.
Bayol A; Breul T; Dupin P; Menegotto J; Aleman C; Duplaa H; Faure P; Bonnet MC; Bauer M
Drug Dev Ind Pharm; 2004 Sep; 30(8):877-89. PubMed ID: 15521333
[TBL] [Abstract][Full Text] [Related]
27. Freeze drying of human serum albumin (HSA) nanoparticles with different excipients.
Anhorn MG; Mahler HC; Langer K
Int J Pharm; 2008 Nov; 363(1-2):162-9. PubMed ID: 18672043
[TBL] [Abstract][Full Text] [Related]
28. Headspace Moisture Mapping and the Information That Can Be Gained about Freeze-Dried Materials and Processes.
Cook IA; Ward KR
PDA J Pharm Sci Technol; 2011; 65(5):457-67. PubMed ID: 22293835
[TBL] [Abstract][Full Text] [Related]
29. Systematic investigation of the effect of lyophilizate collapse on pharmaceutically relevant proteins III: collapse during storage at elevated temperatures.
Schersch K; Betz O; Garidel P; Muehlau S; Bassarab S; Winter G
Eur J Pharm Biopharm; 2013 Oct; 85(2):240-52. PubMed ID: 23727369
[TBL] [Abstract][Full Text] [Related]
30. Effects of cooling rate in microscale and pilot scale freeze-drying - Variations in excipient polymorphs and protein secondary structure.
Peters BH; Staels L; Rantanen J; Molnár F; De Beer T; Lehto VP; Ketolainen J
Eur J Pharm Sci; 2016 Dec; 95():72-81. PubMed ID: 27221369
[TBL] [Abstract][Full Text] [Related]
31. Solute crystallization in mannitol-glycine systems--implications on protein stabilization in freeze-dried formulations.
Pyne A; Chatterjee K; Suryanarayanan R
J Pharm Sci; 2003 Nov; 92(11):2272-83. PubMed ID: 14603512
[TBL] [Abstract][Full Text] [Related]
32. Impact of formulation on the quality and stability of freeze-dried nanoparticles.
Luo WC; O'Reilly Beringhs A; Kim R; Zhang W; Patel SM; Bogner RH; Lu X
Eur J Pharm Biopharm; 2021 Dec; 169():256-267. PubMed ID: 34732383
[TBL] [Abstract][Full Text] [Related]
33. Characterization of the sucrose/glycine/water system by differential scanning calorimetry and freeze-drying microscopy.
Kasraian K; Spitznagel TM; Juneau JA; Yim K
Pharm Dev Technol; 1998 May; 3(2):233-9. PubMed ID: 9653761
[TBL] [Abstract][Full Text] [Related]
34. Formation of mannitol hemihydrate in freeze-dried protein formulations--a design of experiment approach.
Larsen HM; Trnka H; Grohganz H
Int J Pharm; 2014 Jan; 460(1-2):45-52. PubMed ID: 24239581
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of spin freezing versus conventional freezing as part of a continuous pharmaceutical freeze-drying concept for unit doses.
De Meyer L; Van Bockstal PJ; Corver J; Vervaet C; Remon JP; De Beer T
Int J Pharm; 2015 Dec; 496(1):75-85. PubMed ID: 25981618
[TBL] [Abstract][Full Text] [Related]
36. Freeze drying of L-arginine/sucrose-based protein formulations, part I: influence of formulation and arginine counter ion on the critical formulation temperature, product performance and protein stability.
Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
J Pharm Sci; 2015 Jul; 104(7):2345-58. PubMed ID: 25994980
[TBL] [Abstract][Full Text] [Related]
37. Stability characterization and appearance of particulates in a lyophilized formulation of a model peptide hormone-human secretin.
Srinivasan C; Siddiqui A; Korang-Yeboah M; Khan MA
Int J Pharm; 2015 Mar; 481(1-2):104-13. PubMed ID: 25636302
[TBL] [Abstract][Full Text] [Related]
38. The Influence of Mannitol Hemihydrate on the Secondary Drying Dynamics of a Protein Formulation: A Case Study.
Srinivasan JM; Wegiel LA; Hardwick LM; Nail SL
J Pharm Sci; 2017 Dec; 106(12):3583-3590. PubMed ID: 28867201
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms by which crystalline mannitol improves the reconstitution time of high concentration lyophilized protein formulations.
Kulkarni SS; Suryanarayanan R; Rinella JV; Bogner RH
Eur J Pharm Biopharm; 2018 Oct; 131():70-81. PubMed ID: 30056143
[TBL] [Abstract][Full Text] [Related]
40. Humidity induced collapse in freeze dried cakes: A direct visualization study using DVS.
Duralliu A; Matejtschuk P; Williams DR
Eur J Pharm Biopharm; 2018 Jun; 127():29-36. PubMed ID: 29408372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
